View in EDS

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer.
Authors: Radovich M; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Solzak JP; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Wang CJ; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Hancock BA; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Badve S; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana., Althouse SK; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Biostatistics and Data Health Science, Indiana University School of Medicine, Indianapolis, Indiana., Bray SM; LifeOmic, LLC, Indianapolis, Indiana., Storniolo AMV; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Ballinger TJ; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.; Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 02; Vol. 28 (15), pp. 3235-3241.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-21-3078